Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling

Standard

Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling. / Ohnezeit, Denise; Huang, Jiabin; Westerkamp, Ute; Brinschwitz, Veronika; Schmidt, Claudia; Günther, Thomas; Czech-Sioli, Manja; Weißelberg, Samira; Schlemeyer, Tabea; Nakel, Jacqueline; Mai, Julia; Schreiner, Sabrina; Schneider, Carola; Friedel, Caroline C; Schwanke, Hella; Brinkmann, Melanie M; Grundhoff, Adam; Fischer, Nicole.

In: PLOS PATHOG, Vol. 20, No. 8, e1012426, 08.2024.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Ohnezeit, D, Huang, J, Westerkamp, U, Brinschwitz, V, Schmidt, C, Günther, T, Czech-Sioli, M, Weißelberg, S, Schlemeyer, T, Nakel, J, Mai, J, Schreiner, S, Schneider, C, Friedel, CC, Schwanke, H, Brinkmann, MM, Grundhoff, A & Fischer, N 2024, 'Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling', PLOS PATHOG, vol. 20, no. 8, e1012426. https://doi.org/10.1371/journal.ppat.1012426

APA

Ohnezeit, D., Huang, J., Westerkamp, U., Brinschwitz, V., Schmidt, C., Günther, T., Czech-Sioli, M., Weißelberg, S., Schlemeyer, T., Nakel, J., Mai, J., Schreiner, S., Schneider, C., Friedel, C. C., Schwanke, H., Brinkmann, M. M., Grundhoff, A., & Fischer, N. (2024). Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling. PLOS PATHOG, 20(8), [e1012426]. https://doi.org/10.1371/journal.ppat.1012426

Vancouver

Bibtex

@article{902563efda5a464b86f9195f4d5ef964,
title = "Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling",
abstract = "Merkel cell polyomavirus (MCPyV) is the causative agent of the majority of Merkel cell carcinomas (MCC). The virus has limited coding capacity, with its early viral proteins, large T (LT) and small T (sT), being multifunctional and contributing to infection and transformation. A fundamental difference in early viral gene expression between infection and MCPyV-driven tumorigenesis is the expression of a truncated LT (LTtr) in the tumor. In contrast, sT is expressed in both conditions and contributes significantly to oncogenesis. Here, we identified novel functions of early viral proteins by performing genome-wide transcriptome and chromatin studies in primary human fibroblasts. Due to current limitations in infection and tumorigenesis models, we mimic these conditions by ectopically expressing sT, LT or LTtr, individually or in combination, at different time points. In addition to its known function in cell cycle and inflammation modulation, we reveal a fundamentally new function of sT. We show that sT regulates the type I interferon (IFN) response downstream of the type I interferon receptor (IFNAR) by interfering with the interferon-stimulated gene factor 3 (ISGF3)-induced interferon-stimulated gene (ISG) response. Expression of sT leads to a reduction in the expression of interferon regulatory factor 9 (IRF9) which is a central component of the ISGF3 complex. We further show that this function of sT is conserved in BKPyV. We provide a first mechanistic understanding of which early viral proteins trigger and control the type I IFN response, which may influence MCPyV infection, persistence and, during MCC progression, regulation of the tumor microenvironment.",
author = "Denise Ohnezeit and Jiabin Huang and Ute Westerkamp and Veronika Brinschwitz and Claudia Schmidt and Thomas G{\"u}nther and Manja Czech-Sioli and Samira Wei{\ss}elberg and Tabea Schlemeyer and Jacqueline Nakel and Julia Mai and Sabrina Schreiner and Carola Schneider and Friedel, {Caroline C} and Hella Schwanke and Brinkmann, {Melanie M} and Adam Grundhoff and Nicole Fischer",
note = "Copyright: {\textcopyright} 2024 Ohnezeit et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",
year = "2024",
month = aug,
doi = "10.1371/journal.ppat.1012426",
language = "English",
volume = "20",
journal = "PLOS PATHOG",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "8",

}

RIS

TY - JOUR

T1 - Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling

AU - Ohnezeit, Denise

AU - Huang, Jiabin

AU - Westerkamp, Ute

AU - Brinschwitz, Veronika

AU - Schmidt, Claudia

AU - Günther, Thomas

AU - Czech-Sioli, Manja

AU - Weißelberg, Samira

AU - Schlemeyer, Tabea

AU - Nakel, Jacqueline

AU - Mai, Julia

AU - Schreiner, Sabrina

AU - Schneider, Carola

AU - Friedel, Caroline C

AU - Schwanke, Hella

AU - Brinkmann, Melanie M

AU - Grundhoff, Adam

AU - Fischer, Nicole

N1 - Copyright: © 2024 Ohnezeit et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2024/8

Y1 - 2024/8

N2 - Merkel cell polyomavirus (MCPyV) is the causative agent of the majority of Merkel cell carcinomas (MCC). The virus has limited coding capacity, with its early viral proteins, large T (LT) and small T (sT), being multifunctional and contributing to infection and transformation. A fundamental difference in early viral gene expression between infection and MCPyV-driven tumorigenesis is the expression of a truncated LT (LTtr) in the tumor. In contrast, sT is expressed in both conditions and contributes significantly to oncogenesis. Here, we identified novel functions of early viral proteins by performing genome-wide transcriptome and chromatin studies in primary human fibroblasts. Due to current limitations in infection and tumorigenesis models, we mimic these conditions by ectopically expressing sT, LT or LTtr, individually or in combination, at different time points. In addition to its known function in cell cycle and inflammation modulation, we reveal a fundamentally new function of sT. We show that sT regulates the type I interferon (IFN) response downstream of the type I interferon receptor (IFNAR) by interfering with the interferon-stimulated gene factor 3 (ISGF3)-induced interferon-stimulated gene (ISG) response. Expression of sT leads to a reduction in the expression of interferon regulatory factor 9 (IRF9) which is a central component of the ISGF3 complex. We further show that this function of sT is conserved in BKPyV. We provide a first mechanistic understanding of which early viral proteins trigger and control the type I IFN response, which may influence MCPyV infection, persistence and, during MCC progression, regulation of the tumor microenvironment.

AB - Merkel cell polyomavirus (MCPyV) is the causative agent of the majority of Merkel cell carcinomas (MCC). The virus has limited coding capacity, with its early viral proteins, large T (LT) and small T (sT), being multifunctional and contributing to infection and transformation. A fundamental difference in early viral gene expression between infection and MCPyV-driven tumorigenesis is the expression of a truncated LT (LTtr) in the tumor. In contrast, sT is expressed in both conditions and contributes significantly to oncogenesis. Here, we identified novel functions of early viral proteins by performing genome-wide transcriptome and chromatin studies in primary human fibroblasts. Due to current limitations in infection and tumorigenesis models, we mimic these conditions by ectopically expressing sT, LT or LTtr, individually or in combination, at different time points. In addition to its known function in cell cycle and inflammation modulation, we reveal a fundamentally new function of sT. We show that sT regulates the type I interferon (IFN) response downstream of the type I interferon receptor (IFNAR) by interfering with the interferon-stimulated gene factor 3 (ISGF3)-induced interferon-stimulated gene (ISG) response. Expression of sT leads to a reduction in the expression of interferon regulatory factor 9 (IRF9) which is a central component of the ISGF3 complex. We further show that this function of sT is conserved in BKPyV. We provide a first mechanistic understanding of which early viral proteins trigger and control the type I IFN response, which may influence MCPyV infection, persistence and, during MCC progression, regulation of the tumor microenvironment.

U2 - 10.1371/journal.ppat.1012426

DO - 10.1371/journal.ppat.1012426

M3 - SCORING: Journal article

C2 - 39110744

VL - 20

JO - PLOS PATHOG

JF - PLOS PATHOG

SN - 1553-7366

IS - 8

M1 - e1012426

ER -